Back

Next generation sequencing identifies a pattern of novel germline variants in early-onset colorectal cancer

VANDE PERRE, P.; AL SAATI, A.; CABARROU, B.; PLENECASSAGNES, J.; GILHODES, J.; MONSELET, N.; LIGNON, N.; FILLERON, T.; VILLARZEL, C.; GOURDAIN, L.; SELVES, J.; MARTINEZ, M.; CHIPOULET, E.; COLLET, G.; MALLET, L.; BONNET, D.; GUIMBAUD, R.; Toulas, C.

2024-12-12 genetics
10.1101/2024.12.09.627474 bioRxiv
Show abstract

Early-onset colorectal cancer (EOCRC) incidence is increasing rapidly worldwide. However, the majority of EOCRCs are not substantiated by germline variants in the main colorectal cancer (CRC) predisposition genes (the "DIGE" panel). To investigate a potential genetic transmission of EOCRC (dominant, recessive and oligogenic hypotheses) and thus identify potentially novel EOCRC-specific predisposition genes, we conducted an analysis of 585 cancer pathway genes on an EOCRC patient cohort (n=87 patients diagnosed at [≤] 40 years of age, DIGE-) with or without a CRC family history. By comparing this germline variant spectrum to the GnomAD cancer-free database, we identified high impact variants (HVs) in 15 genes significantly over-represented in the EOCRC cohort. Among the 32 unrelated patients with a CRC family history (i.e. with a potentially dominant transmission pattern), nine presented HVs in ten of the genes tested, four of these genes had a DNA repair function. A potentially recessive transmission of EOCRC in patients without a CRC family history cannot be supported by our results nor can an oligogenic transmission. We subsequently sequenced these 15 genes in a cohort of 82 late-onset CRCs (cancer diagnosis [≥]50 years, DIGE-) and found variants in 11 of these genes to be specific to EOCRC. To evaluate whether variants in these 11 genes would allow to specifically detect EOCRC patients, we screened our patient database (n=6482), which only contained 2% of EOCRCs (DIGE-), and identified two other EOCRC cases diagnosed after the constitution of our cohort, with individual HVs in RECQL4 and NUTM1. Altogether, we showed that 37.5% and 18.75% of heterozygous NUTM1 and RECQL4 HVs of our database were diagnosed with EOCRC. Our work has identified a pattern of germline gene variants not previously associated with EOCRC. This paves the way to addressing the contribution of these variants to EOCRC risk and oncogenesis. Author SummaryEarly-onset colorectal cancer (diagnosed at [≤] 40 years of age) is a rare disease that can in part be explained by a hereditary genetic predisposition. To identify novel gene variants potentially associated with EOCRC risk, we analysed a panel of 585 genes in 87 patients with early-onset colorectal cancer unexplained by conventional genetic tests. This first analysis highlighted 15 genes of interest. To evaluate if this genetic profile is specific to early onset, we sequenced these 15 genes in a population of late-onset colorectal cancers (diagnosed after 50 years of age). Variants in 11 of these genes were specific to the early-onset population. To assess if this genetic pattern allows to identify other early-onset cases, we screened these genes in our whole database of 6482 patients and identified two new early-onset cases. Our results need to be confirmed, and validated in larger cohorts but pave the way for future research into early-onset colorectal cancer and the possibility of improving screening or treatment options for these patients and their family members.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
European Journal of Human Genetics
49 papers in training set
Top 0.1%
23.4%
2
Journal of Medical Genetics
28 papers in training set
Top 0.1%
18.2%
3
PLOS Genetics
756 papers in training set
Top 3%
4.5%
4
Scientific Reports
3102 papers in training set
Top 26%
4.5%
50% of probability mass above
5
Genome Medicine
154 papers in training set
Top 2%
4.1%
6
Gut
36 papers in training set
Top 0.2%
3.7%
7
Nature Communications
4913 papers in training set
Top 38%
3.7%
8
EMBO Molecular Medicine
85 papers in training set
Top 0.8%
2.8%
9
Genetics in Medicine
69 papers in training set
Top 0.5%
2.7%
10
Cancers
200 papers in training set
Top 2%
2.2%
11
Human Mutation
29 papers in training set
Top 0.3%
2.0%
12
International Journal of Cancer
42 papers in training set
Top 0.5%
2.0%
13
PLOS ONE
4510 papers in training set
Top 52%
1.8%
14
Frontiers in Genetics
197 papers in training set
Top 5%
1.7%
15
Genes
126 papers in training set
Top 2%
0.8%
16
BMC Cancer
52 papers in training set
Top 2%
0.8%
17
British Journal of Cancer
42 papers in training set
Top 1%
0.8%
18
Nature Genetics
240 papers in training set
Top 7%
0.8%
19
Genome Research
409 papers in training set
Top 4%
0.7%
20
The Journal of Pathology
22 papers in training set
Top 0.5%
0.7%
21
eLife
5422 papers in training set
Top 58%
0.7%
22
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.7%
0.7%
23
Cell Genomics
162 papers in training set
Top 7%
0.7%
24
Gastroenterology
40 papers in training set
Top 2%
0.7%
25
International Journal of Epidemiology
74 papers in training set
Top 3%
0.5%
26
Journal of Clinical Medicine
91 papers in training set
Top 8%
0.5%
27
Genome Biology and Evolution
280 papers in training set
Top 2%
0.5%
28
Nucleic Acids Research
1128 papers in training set
Top 20%
0.5%
29
eClinicalMedicine
55 papers in training set
Top 3%
0.5%
30
American Journal of Gastroenterology
15 papers in training set
Top 0.4%
0.5%